NasdaqGS - Nasdaq Real Time Price USD
Relmada Therapeutics, Inc. (RLMD)
0.7373
+0.0473
+(6.86%)
At close: 4:00:01 PM EDT
0.7400
+0.00
+(0.37%)
After hours: 4:03:44 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-51,755.7980
-51,755.7980
-51,659.2060
-103,801.6170
-91,873.3950
Investing Cash Flow
51,561.5970
51,561.5970
50,453.3320
19,733.6090
-54,118.0360
Financing Cash Flow
-40.3410
-40.3410
-98.4630
45,020.4740
187,939.4730
End Cash Position
3,857.0260
3,857.0260
4,091.5680
5,395.9050
44,443.4390
Issuance of Capital Stock
246.7470
246.7470
--
42,728.5990
185,311.4120
Free Cash Flow
-51,755.7980
-51,755.7980
-51,659.2060
-103,801.6170
-91,873.3950
12/31/2021 - 6/20/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SLXN Silexion Therapeutics Corp
0.9300
-9.71%
PSTV Plus Therapeutics, Inc.
0.8427
-14.32%
VINC Vincerx Pharma, Inc.
0.2750
+7.34%
CHRO Channel Therapeutics Corporation
1.3702
+0.01%
EVGN Evogene Ltd.
1.1100
+1.83%
APVO Aptevo Therapeutics Inc.
0.6916
-6.54%
SCPX Scorpius Holdings, Inc.
0.0680
-48.48%
OBIO Orchestra BioMed Holdings, Inc.
2.5800
-9.47%
RZLT Rezolute, Inc.
3.9600
-0.25%
PRTG Portage Biotech Inc.
9.27
+3.23%